Richter C, Raghunath A, Griffin M, Yaman M, Arruda V, Samelson-Jones B
bioRxiv. 2025; .
PMID: 39896458
PMC: 11785011.
DOI: 10.1101/2024.02.28.582609.
Pontius M, Ku C, Osmond M, Disharoon D, Liu Y, Warnock M
Proc Natl Acad Sci U S A. 2024; 121(10):e2315083121.
PMID: 38408253
PMC: 10927521.
DOI: 10.1073/pnas.2315083121.
Griffin M, Dahlgren A, Nagaswami C, Litvinov R, Keeler K, Madenjian C
J Thromb Haemost. 2023; 22(4):1056-1068.
PMID: 38160724
PMC: 11293624.
DOI: 10.1016/j.jtha.2023.12.025.
Pontius M, Ku C, Osmond M, Disharoon D, Liu Y, Marr D
bioRxiv. 2023; .
PMID: 37745422
PMC: 10515822.
DOI: 10.1101/2023.09.11.557256.
Kocere A, Chiavacci E, Soneson C, Wells H, Mendez-Acevedo K, MacGowan J
bioRxiv. 2023; .
PMID: 37090609
PMC: 10120739.
DOI: 10.1101/2023.04.12.536513.
Direct delivery of plasmin using clot-anchoring thrombin-responsive nanoparticles for targeted fibrinolytic therapy.
Sun M, Pontius M, Yang S, Pendekanti T, Raghunathan S, Shavit J
J Thromb Haemost. 2023; 21(4):983-994.
PMID: 36696210
PMC: 10148984.
DOI: 10.1016/j.jtha.2022.11.037.
Genetic duplication of tissue factor reveals subfunctionalization in venous and arterial hemostasis.
Grzegorski S, Zhao Y, Richter C, Ku C, Lavik K, Paul D
PLoS Genet. 2022; 18(11):e1010534.
PMID: 36449521
PMC: 9744294.
DOI: 10.1371/journal.pgen.1010534.
Fishing for answers to hemostatic and thrombotic disease: Genome editing in zebrafish.
Raghunath A, Ferguson A, Shavit J
Res Pract Thromb Haemost. 2022; 6(5):e12759.
PMID: 35949884
PMC: 9354590.
DOI: 10.1002/rth2.12759.
A genetic modifier of venous thrombosis in zebrafish reveals a functional role for fibrinogen AαE in early hemostasis.
Freire C, Fish R, Vilar R, Di Sanza C, Grzegorski S, Richter C
Blood Adv. 2020; 4(21):5480-5491.
PMID: 33166405
PMC: 7656923.
DOI: 10.1182/bloodadvances.2020001472.
Disruption of the kringle 1 domain of prothrombin leads to late onset mortality in zebrafish.
Grzegorski S, Hu Z, Liu Y, Yu X, Ferguson A, Madarati H
Sci Rep. 2020; 10(1):4049.
PMID: 32132579
PMC: 7055286.
DOI: 10.1038/s41598-020-60840-7.
Analysis of factor V in zebrafish demonstrates minimal levels needed for early hemostasis.
Weyand A, Grzegorski S, Rost M, Lavik K, Ferguson A, Menegatti M
Blood Adv. 2019; 3(11):1670-1680.
PMID: 31167819
PMC: 6560344.
DOI: 10.1182/bloodadvances.2018029066.
Loss of fibrinogen in zebrafish results in an asymptomatic embryonic hemostatic defect and synthetic lethality with thrombocytopenia.
Hu Z, Lavik K, Liu Y, Vo A, Richter C, Di Paola J
J Thromb Haemost. 2019; 17(4):607-617.
PMID: 30663848
PMC: 6443434.
DOI: 10.1111/jth.14391.
Nfe2 is dispensable for early but required for adult thrombocyte formation and function in zebrafish.
Rost M, Shestopalov I, Liu Y, Vo A, Richter C, Emly S
Blood Adv. 2018; 2(23):3418-3427.
PMID: 30504234
PMC: 6290098.
DOI: 10.1182/bloodadvances.2018021865.
Clinical Consequences and Molecular Bases of Low Fibrinogen Levels.
Neerman-Arbez M, Casini A
Int J Mol Sci. 2018; 19(1).
PMID: 29316703
PMC: 5796141.
DOI: 10.3390/ijms19010192.
Genome editing of factor X in zebrafish reveals unexpected tolerance of severe defects in the common pathway.
Hu Z, Liu Y, Huarng M, Menegatti M, Reyon D, Rost M
Blood. 2017; 130(5):666-676.
PMID: 28576875
PMC: 5542852.
DOI: 10.1182/blood-2017-02-765206.